|
Jun 21
|
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
|
|
Jun 21
|
JNJ’s Consistent Payout Makes It a Top Pick for Down Markets
|
|
Jun 20
|
IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant
|
|
Jun 19
|
Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case
|
|
Jun 19
|
J&J MedTech introduces new plates for VOLT fracture management platform
|
|
Jun 18
|
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
|
|
Jun 18
|
Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions
|
|
Jun 18
|
2 Dividend Stocks to Buy and Never Sell
|
|
Jun 18
|
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
|
|
Jun 17
|
Trump's big beautiful bill: What the pharma industry is watching
|
|
Jun 17
|
Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
|
Jun 17
|
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision
|
|
Jun 16
|
Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?
|
|
Jun 16
|
J&J reports results from antibody combo trial for MM patients
|
|
Jun 15
|
Pharma manufacturing 'boom' faces high costs, potential delays
|
|
Jun 15
|
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
|
|
Jun 14
|
Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma
|
|
Jun 14
|
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times
|
|
Jun 14
|
Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)
|
|
Jun 12
|
New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia
|